Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study.
- DOI
- 10.1016/j.ejca.2026.116882
- Published
- 2026-06-13
- Container
- Eur J Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2026.116882,
title = {Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study.},
author = {Louis FM and der Voort AV and Egeler MD and Ramshorst MSV and Mandjes IA and Kemper I and Agterof MJ and der Steeg WAV and Heijns JB and Bekkum MLV and Siemerink EJ and Kuijer PM and Scholten A and Wesseling J and Peeters MTV and Mann RM and de Poll-Franse LVV and Sonke GS and Dutch Breast Cancer Research Group (BOOG).},
year = {2026},
journal = {Eur J Cancer},
doi = {10.1016/j.ejca.2026.116882},
url = {https://doi.org/10.1016/j.ejca.2026.116882}
}RIS
TY - JOUR TI - Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study. AU - Louis FM AU - der Voort AV AU - Egeler MD AU - Ramshorst MSV AU - Mandjes IA AU - Kemper I AU - Agterof MJ AU - der Steeg WAV AU - Heijns JB AU - Bekkum MLV AU - Siemerink EJ AU - Kuijer PM AU - Scholten A AU - Wesseling J AU - Peeters MTV AU - Mann RM AU - de Poll-Franse LVV AU - Sonke GS AU - Dutch Breast Cancer Research Group (BOOG). PY - 2026 JO - Eur J Cancer DO - 10.1016/j.ejca.2026.116882 UR - https://doi.org/10.1016/j.ejca.2026.116882 ER -
APA
FM, L., AV, D. V., MD, E., MSV, R., IA, M., I, K., MJ, A., WAV, D. S., JB, H., MLV, B., EJ, S., PM, K., A, S., J, W., MTV, P., RM, M., LVV, D. P., GS, S., & (BOOG)., D. B. C. R. G. (2026). Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study.. Eur J Cancer. https://doi.org/10.1016/j.ejca.2026.116882
Source records
- europe-pmc · retrieved 2026-09-25T07:57:21.176Z